Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake

Annals of Nuclear Medicine

Volumn 17, Issue 7, 2003, Pages 555-560

  Shozushima, Masanori ^a   Tsutsumi, Reiko ^a   Terasaki, Kazunori ^a   Sato, Shigehiro ^a   Nakamura, Ryuji ^a   Sakamaki, Kimio ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

FDG uptake; Lymphocyte; Macrophage; SRBC immunized splenocyte

Indexed keywords

DEOXYGLUCOSE H 3; ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN; FLUORODEOXYGLUCOSE F 18; THIOGLYCOLIC ACID; TRITIUM; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; ASCITES CELL; CALCULATION; CELL ISOLATION; CELL SUSPENSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG UPTAKE; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; SPLEEN; SPLEEN CELL; T LYMPHOCYTE;

EID: 0242409610     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03006668     Document Type: Article

References (21)

1. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30: 150-185.
2. Nirenberg MW, Hogg JE. Inhibition of anaerobic glycolysis in ehrlich ascites tumor cells by 2-deoxy-D-glucose. Cancer Res 1958; 18: 518-521.
3. Macfarlane DJ, Cotton L, Ackermann RJ, Minn H, Ficaro EP, Shreve PD, et al. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425-429.
4. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996; 198: 225-231.
5. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191: 379-382.
6. Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170: 329-332.
7. 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998; 19: 1189-1196.
8. 18FDG uptake on whole body imaging. Semin Nucl Med 1998; 28: 352-358.
9. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77.
10. Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, et al. O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med 2002; 29: 1039-1046.
11. Bushart GB, Vetter U, Hartmann W. Glucose transport during cell cycle in IM9 lymphocytes. Horm Metab Res 1993; 25: 210-213.
12. Kruisbeek AM. In vitro assays for mouse lymphocyte function. In Current Protocols in Immunology, National Institutes of Health, Colian JE, et al. (eds), 1997: 3.0.1-3.22.4.
13. Harding CV. Antigen processing and presentation. In Current Protocols in Immunology, National Institutes of Health, Colian JE, et al. (eds), 1997: 16.0.1-16.2.15.
14. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19: 1154-1161.
15. Janeway CA, Travers P, Walport M, Capra JD. The induction, measurement, and manipulation of the immune response. In: Immunobiology-The Immune System in Health and Disease, 4th ed., NY; Garland Publishing, 1999: 33-76.
16. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994; 35: 104-112.
17. Shimokawara I, Imamura M, Yamanaka N, Ishii Y, Kikuchi K. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera. Cancer 1982; 49: 1456-1464.
18. Kikuchi K, Shimokawara I, Takami T, et al. Distribution of T and B cells in human cancer tissue. In Immunobiology and Immunotherapy of Cancer (Development in Immunology 6), Terry W, Yamamura Y (eds), New York; Elsevier/North-Holland, 1979: 263.
19. Hiratsuka H, Imamura M, Kasai K, Kamiya H, Ishii Y, Kohama G, et al. Lymphocyte subpopulations and T-cell subsets in human oral cancer tissues: immunohistologic analysis by monoclonal antibodies. Am J Clin Pathol 1984; 81: 464-470.
20. Kawabe J, Okamura T, Shakudo M, Koyama K, Sakamoto H, Ohachi Y, et al. Physiological FDG uptake in the palatine tonsils. Ann Nucl Med 2001; 15: 297-300.
21. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-1312.